Cargando…
Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination
Antibody effector functions have been shown to be influenced by the structure of the Fc N-glycans. Here we studied the changes in plasma or serum IgG Fc N-glycosylation upon vaccination of 10 Caucasian adults and 10 African children. Serum/plasma IgG was purified by affinity chromatography prior to...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322571/ https://www.ncbi.nlm.nih.gov/pubmed/22184099 http://dx.doi.org/10.1074/mcp.M111.014563 |
_version_ | 1782229075747667968 |
---|---|
author | Selman, Maurice H. J. de Jong, Sanne E. Soonawala, Darius Kroon, Frank P. Adegnika, Ayola Akim Deelder, André M. Hokke, Cornelis H. Yazdanbakhsh, Maria Wuhrer, Manfred |
author_facet | Selman, Maurice H. J. de Jong, Sanne E. Soonawala, Darius Kroon, Frank P. Adegnika, Ayola Akim Deelder, André M. Hokke, Cornelis H. Yazdanbakhsh, Maria Wuhrer, Manfred |
author_sort | Selman, Maurice H. J. |
collection | PubMed |
description | Antibody effector functions have been shown to be influenced by the structure of the Fc N-glycans. Here we studied the changes in plasma or serum IgG Fc N-glycosylation upon vaccination of 10 Caucasian adults and 10 African children. Serum/plasma IgG was purified by affinity chromatography prior to and at two time points after vaccination. Fc N-glycosylation profiles of individual IgG subclasses were determined for both total IgG and affinity-purified anti-vaccine IgG using a recently developed fast nanoliquid chromatography-electrospray ionization MS (LC-ESI-MS) method. While vaccination had no effect on the glycosylation of total IgG, anti-vaccine IgG showed increased levels of galactosylation and sialylation upon active immunization. Interestingly, the number of sialic acids per galactose increased during the vaccination time course, suggesting a distinct regulation of galactosylation and sialylation. In addition we observed a decrease in the level of IgG1 bisecting N-acetylglucosamine whereas no significant changes were observed for the level of fucosylation. Our data indicate that dependent on the vaccination time point the infectious agent will encounter IgGs with different glycosylation profiles, which are expected to influence the antibody effector functions relevant in immunity. |
format | Online Article Text |
id | pubmed-3322571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | The American Society for Biochemistry and Molecular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-33225712012-04-12 Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination Selman, Maurice H. J. de Jong, Sanne E. Soonawala, Darius Kroon, Frank P. Adegnika, Ayola Akim Deelder, André M. Hokke, Cornelis H. Yazdanbakhsh, Maria Wuhrer, Manfred Mol Cell Proteomics Research Antibody effector functions have been shown to be influenced by the structure of the Fc N-glycans. Here we studied the changes in plasma or serum IgG Fc N-glycosylation upon vaccination of 10 Caucasian adults and 10 African children. Serum/plasma IgG was purified by affinity chromatography prior to and at two time points after vaccination. Fc N-glycosylation profiles of individual IgG subclasses were determined for both total IgG and affinity-purified anti-vaccine IgG using a recently developed fast nanoliquid chromatography-electrospray ionization MS (LC-ESI-MS) method. While vaccination had no effect on the glycosylation of total IgG, anti-vaccine IgG showed increased levels of galactosylation and sialylation upon active immunization. Interestingly, the number of sialic acids per galactose increased during the vaccination time course, suggesting a distinct regulation of galactosylation and sialylation. In addition we observed a decrease in the level of IgG1 bisecting N-acetylglucosamine whereas no significant changes were observed for the level of fucosylation. Our data indicate that dependent on the vaccination time point the infectious agent will encounter IgGs with different glycosylation profiles, which are expected to influence the antibody effector functions relevant in immunity. The American Society for Biochemistry and Molecular Biology 2012-04 2011-12-19 /pmc/articles/PMC3322571/ /pubmed/22184099 http://dx.doi.org/10.1074/mcp.M111.014563 Text en © 2012 by The American Society for Biochemistry and Molecular Biology, Inc. Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) applies to Author Choice Articles |
spellingShingle | Research Selman, Maurice H. J. de Jong, Sanne E. Soonawala, Darius Kroon, Frank P. Adegnika, Ayola Akim Deelder, André M. Hokke, Cornelis H. Yazdanbakhsh, Maria Wuhrer, Manfred Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination |
title | Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination |
title_full | Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination |
title_fullStr | Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination |
title_full_unstemmed | Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination |
title_short | Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination |
title_sort | changes in antigen-specific igg1 fc n-glycosylation upon influenza and tetanus vaccination |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322571/ https://www.ncbi.nlm.nih.gov/pubmed/22184099 http://dx.doi.org/10.1074/mcp.M111.014563 |
work_keys_str_mv | AT selmanmauricehj changesinantigenspecificigg1fcnglycosylationuponinfluenzaandtetanusvaccination AT dejongsannee changesinantigenspecificigg1fcnglycosylationuponinfluenzaandtetanusvaccination AT soonawaladarius changesinantigenspecificigg1fcnglycosylationuponinfluenzaandtetanusvaccination AT kroonfrankp changesinantigenspecificigg1fcnglycosylationuponinfluenzaandtetanusvaccination AT adegnikaayolaakim changesinantigenspecificigg1fcnglycosylationuponinfluenzaandtetanusvaccination AT deelderandrem changesinantigenspecificigg1fcnglycosylationuponinfluenzaandtetanusvaccination AT hokkecornelish changesinantigenspecificigg1fcnglycosylationuponinfluenzaandtetanusvaccination AT yazdanbakhshmaria changesinantigenspecificigg1fcnglycosylationuponinfluenzaandtetanusvaccination AT wuhrermanfred changesinantigenspecificigg1fcnglycosylationuponinfluenzaandtetanusvaccination |